6th May 2021
News
Sygnature appoints Dr David Lustig to spearhead US expansion
27th April 2021
Drug Discovery News
Sygnature Discovery expands US presence with Bay Area office
1st April 2021
News
Legendary Werewolf: A Freak Chemistry Accident at Sygnature!
25th March 2021
DMPK in vivo pharmacology News
Leading UK Drug Discovery CROs Unite as Sygnature Discovery
18th February 2021
Drug Discovery News
Sygnature Discovery Opens Second Drug Discovery Site at Alderley Park
10th February 2021
Blog Events News
Powerful Webinar Series Unites Sygnature and Altasciences
5th February 2021
Awards News
Sygnature Discovery named Company of the Year at Bionow Annual Awards
21st January 2021
Computational Sciences and Informatics Drug Discovery News
Enhancing Molecular Design Services: Sygnature Discovery Adopts OpenEye’s Orion™ Platform
19th January 2021
Awards News
Sygnature Discovery shortlisted for BioNow Company of the Year Award
18th January 2021
Bioscience News
Sygnature upgrades western blotting capability with Jess instrument from Protein Simple
8th January 2021
News
Dr Paul Overton becomes Chief Commercial Officer (CCO) at Sygnature Discovery
10th December 2020
News
What happened? A 2020 Recap!